ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Dr Martini talks about the prize-winning abstract he presented at EAU 2021 on patterns of recurrence after a radical nephroureterectomy in patients with high-risk upper tract urothelial carcinoma.
He explains that the study used a multi-institutional database to assess over 1,100 patients considered high-risk, according to European Association of Urology guidelines, in order to review whether the follow-up process for those patients was appropriate or needed revising.
Dr Martini discusses patterns and locations of recurrence in relation to a follow-up regimen consisting of cystoscopies and imaging diagnostics. He mentions that patients with a prior history of urothelial cancer in the bladder not only have a higher risk of developing urothelial cancer in the upper urinary tract but are also more likely to suffer from recurrences after radical nephroureterectomies.
Finally, he discusses the relevance of adjuvant chemotherapy after surgery and proposals for an adjustment in the timing of imaging and cystoscopy follow-up for high-risk urothelial carcinoma.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Durable responses in aRCC, how do we optimise treatment?
OncoAlert Round Up for September 15-21, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
The advantages of IORT for early breast cancer treatment
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery
Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer
Surgical technique remains the most important factor associated with recovery of urinary continence after radical prostatectomy